Intelligence Platform
Patents
Browse 82 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7994211
Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
granted patentUS 7977312
Compositions and methods for increasing bone mineralization
granted patentUS 7846955
Salt
granted patentUS 7758858
Antibodies associated with alterations in bone density
granted patentUS 7413538
Epitopes formed by non-covalent association of conjugates
granted patentUS 7192583
Methods for modulating bone mineralization
granted patentUS 6933306
Hydroxamic and carboxylic acid derivatives
expired patentUS 6884618
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired patentUS 6818622
Selective MMP inhibitors having reduced side-effects
expired patentUS 6809100
Hydroxamic acid derivatives
expired patentUS 6803453
Antibodies associated with alterations in bone density
expired patentUS 6794145
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired patentUS 6787536
Hydroxamic acid derivatives
expired patentUS 6734189
Hydroxamic and carboxylic acid derivatives
expired patentUS 6706719
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
expired patentUS 6706257
Sunless tanning products and processes
expired patentUS 6683171
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired patentUS 6683160
Antibodies specific for Fkhsf gene products
expired patentUS 6667162
Identification of the gene causing the mouse scurfy phenotype and its human ortholog
expired patentUS 6514994
Levobupivacaine and its use
expired patentUS 6506773
Hydroxamic and carboxylic acid derivatives
expired patentUS 6506764
Hydroxamic and carboxylic acid derivatives
expired patentUS 6503910
Hydroxamic and carboxylic acid derivatives
expired patentUS 6495736
Compositions and methods for increasing bone mineralization
expired